Outcome | Grade | Studies | ||||||
---|---|---|---|---|---|---|---|---|
Skin Thickness |
C
|
|
||||||
Skin Elasticity |
D
|
|
||||||
Wrinkles |
D
|
|
||||||
Skin Firmness |
D
|
|
||||||
Skin Barrier Function |
D
|
|
Outcome | Grade | Studies | ||||||
---|---|---|---|---|---|---|---|---|
CRABP2 |
D
|
|
||||||
Bacterial Activity |
D
|
|
||||||
Filaggrin |
D
|
|
||||||
Involucrin |
D
|
|
||||||
Transglutaminase |
D
|
|
Outcome | Frequency | Studies | ||||||
---|---|---|---|---|---|---|---|---|
Peeling |
|
|
||||||
Skin Redness |
|
|
||||||
Irritation |
|
|
Intervention | Retinal |
---|---|
Concern | Skin Thickness |
Subject Type | Human |
Trial Design |
Non-Randomised Controlled |
Intervention | Retinal |
---|---|
Concern | Skin Thickness |
Subject Type | Human |
Trial Design |
Non-Randomised Uncontrolled |
Trial Duration | 365 days |
Participants | 44 |
Intervention | Retinal |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Non-Randomised Uncontrolled |
Trial Duration | 365 days |
Participants | 44 |
Intervention | Retinal |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Double-Blind Non-Randomised Controlled |
Trial Duration | 308 days |
Participants | 355 |